iotaMotion Launches First Robotic-Assisted Cochlear Implant Procedure Outside the U.S
May 14, 2025
Swiss Clinical Trial Marks Key Step in Global Expansion of Precision Hearing Implant Technology
Swiss Clinical Trial Marks Key Step in Global Expansion of Precision Hearing Implant Technology
Milestone strengthens regenerative medicine in Europe with top-tier safety, quality standards, and exclusive distribution via Aspire Medical.
Next-Gen Hearing Wellness Device Offers Self-Fitting, Enhanced Sound Processing, and Seamless App Integration
Advanced Preservation System Demonstrates Critical Role in Long-Distance Organ Transport and Transplant Outcomes
This newly designed catheter offers many advantages over the current Foley catheter in use today.
Axoft announced today that it made its Fleuron ultra-soft brain implant material available for purchase for R&D applications.
EnVVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.
Terumo Neuro (formerly MicroVention) announced that it launched its Sofia 88 neurovascular support catheter in the U.S.
FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world’s first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput.
A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in vivo conditions of patient-derived cancer cells. This innovative model not only simulates the tumor microenvironment but also integrates artificial intelligence (AI) technology that can predict patient prognosis solely from images of tumor growth.